130 related articles for article (PubMed ID: 9780152)
1. Long-lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines.
Youssef S; Wildbaum G; Maor G; Lanir N; Gour-Lavie A; Grabie N; Karin N
J Immunol; 1998 Oct; 161(8):3870-9. PubMed ID: 9780152
[TBL] [Abstract][Full Text] [Related]
2. Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines.
Youssef S; Wildbaum G; Karin N
J Autoimmun; 1999 Aug; 13(1):21-9. PubMed ID: 10441164
[TBL] [Abstract][Full Text] [Related]
3. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation.
Karpus WJ; Kennedy KJ
J Leukoc Biol; 1997 Nov; 62(5):681-7. PubMed ID: 9365124
[TBL] [Abstract][Full Text] [Related]
4. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
Adamus G; Manczak M; Machnicki M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
[TBL] [Abstract][Full Text] [Related]
5. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
[TBL] [Abstract][Full Text] [Related]
6. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
Lobell A; Weissert R; Eltayeb S; Svanholm C; Olsson T; Wigzell H
J Immunol; 1999 Nov; 163(9):4754-62. PubMed ID: 10528174
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis.
Wildbaum G; Karin N
Gene Ther; 1999 Jun; 6(6):1128-38. PubMed ID: 10455416
[TBL] [Abstract][Full Text] [Related]
8. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis.
Wildbaum G; Youssef S; Grabie N; Karin N
J Immunol; 1998 Dec; 161(11):6368-74. PubMed ID: 9834127
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines.
Karin N
Isr Med Assoc J; 2000 Jul; 2 Suppl():63-8. PubMed ID: 10909420
[TBL] [Abstract][Full Text] [Related]
11. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo.
Kopydlowski KM; Salkowski CA; Cody MJ; van Rooijen N; Major J; Hamilton TA; Vogel SN
J Immunol; 1999 Aug; 163(3):1537-44. PubMed ID: 10415057
[TBL] [Abstract][Full Text] [Related]
12. Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
Mueller AM; Pedré X; Kleiter I; Hornberg M; Steinbrecher A; Giegerich G
J Neuroimmunol; 2005 Feb; 159(1-2):55-65. PubMed ID: 15652403
[TBL] [Abstract][Full Text] [Related]
13. Protection from autoimmunity by DNA vaccination against T-cell receptor.
Buch T; Waisman A
Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
[TBL] [Abstract][Full Text] [Related]
14. Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES.
Jia Y; Li H; Chen W; Li M; Lv M; Feng P; Hu H; Zhang L
Gene Ther; 2006 Sep; 13(18):1351-9. PubMed ID: 16708076
[TBL] [Abstract][Full Text] [Related]
15. Immunization with pVAXhsp65 decreases inflammation and modulates immune response in experimental encephalomyelitis.
Zorzella-Pezavento SF; Chiuso-Minicucci F; França TG; Ishikawa LL; Martins DR; Silva CL; Sartori A
Neuroimmunomodulation; 2010; 17(5):287-97. PubMed ID: 20407280
[TBL] [Abstract][Full Text] [Related]
16. Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen.
Weissert R; Lobell A; de Graaf KL; Eltayeb SY; Andersson R; Olsson T; Wigzell H
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1689-94. PubMed ID: 10677519
[TBL] [Abstract][Full Text] [Related]
17. Impaired autoimmune T helper 17 cell responses following DNA vaccination against rat experimental autoimmune encephalomyelitis.
Andersson A; Isaksson M; Wefer J; Norling A; Flores-Morales A; Rorsman F; Kämpe O; Harris RA; Lobell A
PLoS One; 2008; 3(11):e3682. PubMed ID: 18997868
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
19. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.
Glabinski AR; Bielecki B; Kawczak JA; Tuohy VK; Selmaj K; Ransohoff RM
Autoimmunity; 2004; 37(6-7):465-71. PubMed ID: 15621573
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18.
Guan P; Burghes AH; Cunningham A; Lira P; Brissette WH; Neote K; McColl SR
Genomics; 1999 Mar; 56(3):296-302. PubMed ID: 10087196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
